NASDAQ

Intellia Therapeutics, Inc. (NTLA)

♥ 651 Thanks from members

Live price chart, market sentiment, and community perspectives for Intellia Therapeutics, Inc. (NASDAQ: NTLA).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Jennifer DoudnaFounder: Intellia TherapeuticsLeadership: John Leonard (CEO)Leadership: Maan Bukhamseen (CFO)Holder: ARK Investment ManagementHolder: Vanguard GroupHolder: Novartis AGNTLA-2001NTLA-2002CRISPR In Vivo Gene Editing Pipeline#NTLA stock#Intellia Therapeutics#CRISPR gene editing#genetic medicine#NASDAQ NTLA